Evidence map›Paper›PMID 40672729›Full record

ArticlePostepy dermatologii i alergologii2025

Clinical characteristics of asthma-chronic obstructive pulmonary disease overlap phenotypes.

Özge Atik, Fatma Merve Tepetam, Şeyma Özden, Ayşe Ezgi Ak

Abstract read
In one paragraph

Article in Postepy dermatologii i alergologii, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Özge AtikDepartment of Immunology and Allergy, University of Health Sciences Süreyyapasa Chest Disease and Chest Surgery Training and Research Hospital, Istanbul, Türkiye.
Fatma Merve TepetamDepartment of Immunology and Allergy, University of Health Sciences Süreyyapasa Chest Disease and Chest Surgery Training and Research Hospital, Istanbul, Türkiye.
Şeyma ÖzdenDepartment of Immunology and Allergy, University of Health Sciences Süreyyapasa Chest Disease and Chest Surgery Training and Research Hospital, Istanbul, Türkiye.
Ayşe Ezgi AkDepartment of Chest Disease, University of Health Sciences Süreyyapasa Chest Disease and Chest Surgery Training and Research Hospital, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Asthma-chronic obstructive pulmonary disease overlap (ACO) patients are categorized as those with persistent airflow limitation and features of asthma and chronic obstructive pulmonary disease (COPD). Aim: This study aimed to identify ACO subgroups based on atopy, bronchodilator response (BDR), and eosinophil count. Material and methods: From 2021 to 2024, we conducted a retrospective study on patients with asthma and/or COPD who underwent BDR testing. An ACO diagnosis required persistent airflow limitation, a history of asthma before the age of 40 or significant BDR, and at least one minor criterion. Patients were grouped by atopy status, BDR presence, and eosinophil count. We compared demographic, laboratory, spirometry, and medication data across subgroups. Results: The study included 109 ACO patients with a mean age of 49.5 ±10.7 years. Atopic ACO patients showed a higher increase in FEV Conclusions: Higher ΔFEV

Indexed as

asthmaasthma-chronic obstructive pulmonary disease overlapchronic obstructive pulmonary diseasephenotype

Identifiers

PMID40672729
PMCPMC12262034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.